BioNTech Balance Sheet Health
Financial Health criteria checks 6/6
BioNTech has a total shareholder equity of €19.1B and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €22.4B and €3.3B respectively.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | n/a |
| Cash | €16.71b |
| Equity | €19.11b |
| Total liabilities | €3.29b |
| Total assets | €22.40b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 22UA's short term assets (€18.5B) exceed its short term liabilities (€2.5B).
Long Term Liabilities: 22UA's short term assets (€18.5B) exceed its long term liabilities (€764.2M).
Debt to Equity History and Analysis
Debt Level: 22UA is debt free.
Reducing Debt: 22UA has no debt compared to 5 years ago when its debt to equity ratio was 3.3%.
Debt Coverage: 22UA has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 22UA has no debt, therefore coverage of interest payments is not a concern.